Jump to content
  • Sign Up
0
Scott Adams

Alvine Pharmaceuticals: ALV003 Shows Promise in Celiac Disease Patients - Celiac.com

Rate this topic

Recommended Posts

6.jpg

Celiac.com

Alvine Pharmaceuticals: ALV003 Shows Promise in Celiac Disease Patients

Celiac.com

Celiac.com 11/14/2011 - Alvine Pharmaceuticals claims that Phase 2a clinical trial of ALV003 demonstrates the drug's ability to mitigate gluten-triggered intestinal mucosal damage in serologically negative celiac disease patients who followed a ...

View the full article

Share this post


Link to post
Share on other sites

This is good news. We might have something to help protect against CC. It's a pity it only mitigates damage rather than prevents it, but I'm not at all surprised when I saw the amount of time it takes to break down gliadin in a test tube.

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×